Article Text

Download PDFPDF
Randomised controlled trial
Statins induce hyperglycaemia of uncertain importance
  1. Victor M Montori,
  2. Juan P Brito
  1. Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA
  1. Correspondence to : Victor M Montori
    Division of Endocrinology, Diabetes, Metabolism and Nutrition Rochester, Mayo Clinic, Minnesota, USA; Montori.Victor{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlCrossRefPubMedWeb of Science


Statins effectively reduce cardiovascular risk. Although generally safe, their use has been associated with muscle discomfort, myopathy, neuropathy and, rarely, rhadbomyolysis. Since February 2012, statin labels carry a new warning: their use is associated with elevated blood glucose levels.

Whereas the mechanism remains unknown, several meta-analyses have substantiated the relationship between statin use and elevation of blood glucose levels. As glucose levels rise, some (those close to the threshold at the outset) will cross the arbitrary threshold for the diagnosis of diabetes. Meta-analyses …

View Full Text


  • Competing interests None.